Australia is currently living through a chronic disease crisis, luckily there are startups on a mission to solve this crisis. 

Vively a metabolic wellness platform, that utilises continuous glucose monitors to highlight how diet and lifestyle choices impact metabolic health has secured $1.5 million in oversubscribed pre-seed funding, led by Archangel Ventures. The health tech uses constant glucose monitoring via an arm patch to help people understand how their diet and lifestyle is impacting their health. 

The platform is only three months old, but has already claimed $1 million in annualised revenue and almost 100% month-on-month growth.

https://www.smartcompany.com.au/startupsmart/news/six-startup-funding-deals/